These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35687788)

  • 41. Psychiatrists' decision making between branded and generic drugs.
    Hamann J; Mendel R; Kissling W; Leucht S
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):686-90. PubMed ID: 23021566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Philosophy of clinical psychopharmacology.
    Aragona M
    Psychiatr Danub; 2013 Mar; 25(1):4-10. PubMed ID: 23470600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychiatrists' Attitude and Use of Second-generation Antipsychotics for the Treatment of Schizophrenia in Taiwan.
    Chen CK; Su HH; Sun IW
    East Asian Arch Psychiatry; 2017 Sep; 27(3):91-6. PubMed ID: 28993541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive biases, environmental, patient and personal factors associated with critical care decision making: A scoping review.
    Beldhuis IE; Marapin RS; Jiang YY; Simões de Souza NF; Georgiou A; Kaufmann T; Castela Forte J; van der Horst ICC
    J Crit Care; 2021 Aug; 64():144-153. PubMed ID: 33906103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children: Child and Adolescent Psychiatrists' Adherence to Clinical Practice Guidelines.
    Chung J; Tchaconas A; Meryash D; Adesman A
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):335-43. PubMed ID: 27105063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoids.
    Jacobs NI; Montebello M; Monds LA; Lintzeris N
    Australas Psychiatry; 2019 Feb; 27(1):80-85. PubMed ID: 30298754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of managed care and financing in medical practices: how does psychiatry differ from other medical fields?
    Sturm R; Ringel JS
    Soc Psychiatry Psychiatr Epidemiol; 2003 Aug; 38(8):427-35. PubMed ID: 12910338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specialty training and the personal use of benzodiazepines by physicians affect their proneness to prescribe tranquilizers.
    Linden M; Gothe H
    Pharmacopsychiatry; 1998 Mar; 31(2):42-7. PubMed ID: 9562207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices.
    Knappich M; Hörz-Sagstetter S; Schwerthöffer D; Leucht S; Rentrop M
    Int Clin Psychopharmacol; 2014 Jul; 29(4):224-8. PubMed ID: 24896541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychiatrists' treatment preferences for generalized anxiety disorder.
    Latas M; Trajković G; Bonevski D; Naumovska A; Vučinić Latas D; Bukumirić Z; Starčević V
    Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29266492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Off-Label Use of Second-generation Antipsychotics in Bipolar Disorder: A Survey of Italian Psychiatrists.
    Salvi V; Cerveri G; Aguglia A; Calò S; Corbo M; Martinotti G; Serafini G; Signorelli MS; Aguglia E; Amore M; Biggio G; DI Sciascio G; Mencacci C
    J Psychiatr Pract; 2019 Jul; 25(4):318-327. PubMed ID: 31291215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Innovative Needs Assessment Approach to Develop Relevant Continuing Professional Development for Psychiatrists.
    Luconi F; Montoro R; Lalla L; Teferra M
    Acad Psychiatry; 2022 Feb; 46(1):106-113. PubMed ID: 34846721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opinions Regarding Benzodiazepine Teaching and Prescribing Among Trainees in Psychiatry.
    Garakani A; Abdullah HM; Chang CM; Mendelsohn N; Lapidus KAB
    Acad Psychiatry; 2018 Apr; 42(2):297-303. PubMed ID: 28685349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with antipsychotic drug prescribing by southern psychiatrists.
    Benson PR
    Med Care; 1983 Jun; 21(6):639-54. PubMed ID: 6134878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knowledge and attitudes about transcranial magnetic stimulation among psychiatrists in China.
    Deng J; Gong Y; Lin X; Bao Y; Sun H; Lu L
    BMC Psychiatry; 2020 Aug; 20(1):416. PubMed ID: 32831049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
    Pan K; Silver S; Davis C
    Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gating the holes in the Swiss cheese (part I): Expanding professor Reason's model for patient safety.
    Seshia SS; Bryan Young G; Makhinson M; Smith PA; Stobart K; Croskerry P
    J Eval Clin Pract; 2018 Feb; 24(1):187-197. PubMed ID: 29168290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychiatric outpatients' self-reported adherence versus psychiatrists' impressions on adherence in affective disorders.
    De las Cuevas C; Peñate W; Sanz EJ
    Hum Psychopharmacol; 2013 Mar; 28(2):142-50. PubMed ID: 23475396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychiatrists' reflections on a medication-free program for patients with psychosis.
    Yeisen RA; Bjørnestad J; Joa I; Johannessen JO; Opjordsmoen S
    J Psychopharmacol; 2019 Apr; 33(4):459-465. PubMed ID: 30676216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Impact of Patient Suicide on the Professional Practice of Swiss Psychiatrists and Psychologists.
    Gulfi A; Castelli Dransart DA; Heeb JL; Gutjahr E
    Acad Psychiatry; 2016 Feb; 40(1):13-22. PubMed ID: 25572177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.